66
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Non-Hodgkin lymphoma.

      Lancet
      Antineoplastic Agents, therapeutic use, Humans, Lymphoma, Non-Hodgkin, classification, diagnosis, drug therapy, epidemiology, Neoplasm Staging, Prognosis

      Read this article at

      ScienceOpenPublisherPubMed
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Lymphomas are solid tumours of the immune system. Hodgkin's lymphoma accounts for about 10% of all lymphomas, and the remaining 90% are referred to as non-Hodgkin lymphoma. Non-Hodgkin lymphomas have a wide range of histological appearances and clinical features at presentation, which can make diagnosis difficult. Lymphomas are not rare, and most physicians, irrespective of their specialty, will probably have come across a patient with lymphoma. Timely diagnosis is important because effective, and often curative, therapies are available for many subtypes. In this Seminar we discuss advances in the understanding of the biology of these malignancies and new, available treatments. Copyright © 2012 Elsevier Ltd. All rights reserved.

          Related collections

          Author and article information

          Journal
          22835603
          10.1016/S0140-6736(12)60605-9

          Chemistry
          Antineoplastic Agents,therapeutic use,Humans,Lymphoma, Non-Hodgkin,classification,diagnosis,drug therapy,epidemiology,Neoplasm Staging,Prognosis

          Comments

          Comment on this article